RobertMichaelCuddihyMD
Endocrinology • Lebanon, NHDiabetes, Lipid Metabolism
Section Chief, Endocrinology, Diabetes, and Metabolism, Dartmouth-Hitchcock Medical Center Associate Professor of Medicine, Geisel School of Medicine at Dartmouth
Dr. Cuddihy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1 Medical Center Dr
Lebanon, NH 03756Phone+1 603-650-5000- Is this information wrong?
Summary
- Dr. Robert Cuddihy is an endocrinologist in Lebanon, NH. He received his medical degree from UMass Chan Medical School and has been in practice 28 years. He specializes in diabetes and lipid metabolism. He has more than 30 publications and over 500 citings.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 1992 - 1994
Maine Medical CenterResidency, Internal Medicine, 1989 - 1992
University of Massachusetts Medical SchoolClass of 1989
Certifications & Licensure
ME State Medical License 2023 - 2026
NH State Medical License 2023 - 2025
VT State Medical License 2023 - 2024
MN State Medical License 1992 - 2024
MA State Medical License 2003 - 2008- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Observational Study of Interstitial Glucose Monitoring With Continuous Glucose Monitoring to Track Patients Treated With Exenatide Start of enrollment: 2007 Jan 01
- Hypertension and Diabetes Initiative - Improving Hypertension Control in Individuals With Diabetes Start of enrollment: 2006 Dec 01
- Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control Start of enrollment: 2008 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 24 citationsDNA methylation age calculators reveal association with diabetic neuropathy in type 1 diabetes.Delnaz Roshandel, Zhuo Chen, Angelo J. Canty, Shelley B. Bull, Rama Natarajan, Andrew D. Paterson, Stephen W. Scherer, F. Miao, L. Zhang, J. Brown-Friday, Jill P. Cran...> ;Clinical Epigenetics. 2020 Apr 5
- 151 citationsEffects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetesW. Timothy Garvey, Luc Van Gaal, Lawrence A. Leiter, Ujjwala Vijapurkar, James List, Robert Cuddihy, Jimmy Ren, Michael J. Davies> ;Metabolism. 2018 Aug 1
- 7 citationsQuality Control Measures over 30 Years in a Multicenter Clinical Study: Results from the Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventi...Gayle M. Lorenzi, Barbara H. Braffett, Valerie L. Arends, Ronald P. Danis, Lisa Diminick, Kandace A. Klumpp, Anthony D. Morrison, Elsayed Z. Soliman, Michael W. Steffe...> ;Plos One. 2015 Nov 3
- Join now to see all
Press Mentions
Female Founded and Funded Capsida Taps Swati Tole as Chief Medical OfficerJune 1st, 2021- Capsida Appoints Swati Tole, M.D., as Chief Medical OfficerMay 12th, 2021
- Capsida Biotherapeutics Emerges from Stealth with $140mMay 6th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
